Search Results
(
)
Filter by
Filter by health areas, people and populations, or solutions
Filter by EGPAF’s stories, research, resources or news
Journal Articles
Clinical Impact and Cost-Effectiveness of Improving Access to Cryptococcal Meningitis Diagnostics and Treatment in Malawi
Published May 27, 2026
Abstract Background Cryptococcal meningitis (CM) causes 13%–20% of deaths among people living with HIV (PLHIV) globally. We examined the cost-effectiveness of improving access to CM diagnostics and treatment among PLHIV initiating HIV care with a positive serum cryptococcal antigen (CrAg) test in Malawi. Methods We used the CEPAC-I model to…
Topics:
HIV
Countries:
Malawi
Journal Articles
Patient tracking and retention with Malawi’s electronic medical records system in antiretroviral treatment clinics
Published May 3, 2026
A 2026 study in Malawi shows that electronic medical record tools can improve HIV patient retention by quickly identifying missed appointments and enabling timely follow-up, strengthening continuity of care.
Topics:
Digital Health
Countries:
Malawi
Journal Articles
Retention in HIV care before and after implementation of a case management program in Malawi
Published April 8, 2026
Authored by EGPAF-Malawi:Lucky Makonokaya, Shalom Dunga, Louiser Kalitera, Rachel Chamanga, Lazarous Msuku, Cathy Golowa, Zuze Joaki, Ackim Sankhani, Geoffrey Singini, Samantha Makoko, Lilian Jiah, Rhoderick Machekano, Godfrey Woelk & Thulani Maphosa Abstract Background Retaining persons living with HIV (PLHIV) on antiretroviral therapy (ART) and preventing loss-to-follow-up (LTFU) is an ongoing challenge. In Malawi, the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) implemented a facility-based…
Topics:
HIV
Countries:
Malawi
Issue Briefs
Accelerating Progress to Ending Pediatric HIV
Published March 30, 2026
We are at a critical inflection point for children affected by HIV. In 2024 alone, 120,000 children were newly infected, and, without timely treatment, half of HIV positive infants will not reach their second birthday. Children remain left behind—a child with HIV is 6 times more likely to die than…
Topics:
HIV,
Pediatric HIV
Countries:
Global
Fact Sheets
Resource
Protecting Lives, Sustaining Progress
Published March 15, 2026
The following landscape analysis of maternal and child health, HIV prevention, diagnosis, and treatment, and the historic strength of U.S. leadership in global aid provides an overview of these key areas of global health and recommendations for U.S. Congressional engagement and prioritization.
Topics:
Advocacy,
Children,
Global Health Security,
Health System Strengthening,
HIV,
Maternal and Child Health,
Mothers and Infants,
Women
Countries:
Global,
United States
Journal Articles
Tuberculosis Preventive Treatment Uptake Among Patients Initiating Antiretroviral Therapy in Malawi: Children Left Behind
Published November 24, 2025
Background: Tuberculosis preventive treatment (TPT) is recommended for people living with HIV (PLHIV) to reduce the tuberculosis (TB) incidence in regions with a high prevalence of TB. We evaluated the uptake and completion of TPT among newly initiated antiretroviral therapy (ART) patients in a programme setting in Malawi. Objectives: To describe TPT…
Topics:
Pediatric Tuberculosis (TB),
Tuberculosis (TB)
Countries:
Malawi
Project Brief
Integrating Nurturing Care for Early Childhood Development into Primary Health Care: The Tanzania Experience
Published July 23, 2025
Overview More than 275 million children in low- and middle-income countries are at risk of suboptimal development, including over 66% of children in sub-Saharan Africa. In Tanzania 43% of children are at high risk of not achieving their full potential for growth and development. Risk factors for suboptimal development include…
Countries:
Tanzania
Journal Articles
Accelerating Access to Paediatric Medicines
Published April 15, 2025
Overview Despite progress in reducing neonatal and child mortality, access to age-appropriate medicines remains inequitable, particularly in low-income and middle-income countries. The Global Accelerator for Paediatric Formulations (GAP-f), a WHO-hosted network established in 2020, addresses these gaps by uniting 33 partners to promote innovation and access to child-friendly formulations. Phase…